These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23443941)

  • 1. Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.
    Seipel AH; Wiklund F; Wiklund NP; Egevad L
    Virchows Arch; 2013 Apr; 462(4):429-36. PubMed ID: 23443941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features.
    Seipel AH; Delahunt B; Samaratunga H; Egevad L
    Pathology; 2016 Aug; 48(5):398-405. PubMed ID: 27321992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.
    Au S; Villamil CF; Alaghehbandan R; Wang G
    Ann Diagn Pathol; 2019 Apr; 39():59-62. PubMed ID: 30772651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma.
    Amin A; Epstein JI
    Am J Surg Pathol; 2011 Apr; 35(4):615-9. PubMed ID: 21383610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort.
    Trudel D; Downes MR; Sykes J; Kron KJ; Trachtenberg J; van der Kwast TH
    Eur J Cancer; 2014 Jun; 50(9):1610-6. PubMed ID: 24703897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.
    Samaratunga H; Duffy D; Yaxley J; Delahunt B
    Hum Pathol; 2010 Feb; 41(2):281-5. PubMed ID: 20004936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIN-like (Ductal) Adenocarcinoma of the Prostate.
    Paulk A; Giannico G; Epstein JI
    Am J Surg Pathol; 2018 Dec; 42(12):1693-1700. PubMed ID: 30138215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prostatic central zone adenocarcinoma.
    Mai KT; Belanger EC; Al-Maghrabi HM; Robertson S; Wang D; Margnean C
    Pathol Res Pract; 2008; 204(4):251-8. PubMed ID: 18178014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists.
    Seipel AH; Delahunt B; Samaratunga H; Amin M; Barton J; Berney DM; Billis A; Cheng L; Comperat E; Evans A; Fine SW; Grignon D; Humphrey PA; Magi-Galluzzi C; Montironi R; Sesterhenn I; Srigley JR; Trpkov K; van der Kwast T; Varma M; Zhou M; Ahmad A; Moss S; Egevad L
    Histopathology; 2014 Aug; 65(2):216-27. PubMed ID: 24467262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal Adenocarcinoma of the Prostate With Cribriform or Papillary Ductal Morphology: Rare Biopsy Cases Lacking Associated Invasive High-grade Carcinoma.
    Russell DH; Epstein JI
    Am J Surg Pathol; 2022 Feb; 46(2):233-240. PubMed ID: 34619708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer.
    Murata Y; Tatsugami K; Yoshikawa M; Hamaguchi M; Yamada S; Hayakawa Y; Ueda K; Momosaki S; Sakamoto N
    Int J Urol; 2018 Mar; 25(3):284-289. PubMed ID: 29315854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic ductal adenocarcinoma: a mini review.
    Epstein JI
    Med Princ Pract; 2010; 19(1):82-5. PubMed ID: 19996627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility study of ADCs targeting TROP-2, HER2, and CD46 in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate.
    Wang X; Qi L; Chen M; Zhang Y; Gao X; Cai Y
    World J Urol; 2024 Jul; 42(1):404. PubMed ID: 38990246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression.
    Brinker DA; Potter SR; Epstein JI
    Am J Surg Pathol; 1999 Dec; 23(12):1471-9. PubMed ID: 10584700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does prostatic ductal adenocarcinoma exist?
    Bock BJ; Bostwick DG
    Am J Surg Pathol; 1999 Jul; 23(7):781-5. PubMed ID: 10403300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate ductal adenocarcinoma exhibiting a late recurrence in the anterior urethra 13 years post-total prostatectomy: a case report.
    Honda S; Kawahara T; Tanaka R; Yuguchi S; Yamanaka S; Fujii S; Hasizume A; Osaka K; Mimura N; Karibe J; Noguchi T; Shimokihara K; Takamoto D; Takeshima T; Teranishi JI; Makiyama K; Uemura H
    J Med Case Rep; 2024 Aug; 18(1):371. PubMed ID: 39152479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic profile of ductal adenocarcinoma of the prostate.
    Seipel AH; Whitington T; Delahunt B; Samaratunga H; Mayrhofer M; Wiklund P; Grönberg H; Lindberg J; Egevad L
    Hum Pathol; 2017 Nov; 69():1-7. PubMed ID: 28457729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases.
    Lee S; Han JS; Chang A; Ross HM; Montironi R; Yorukoglu K; Lane Z; Epstein JI
    Hum Pathol; 2013 Mar; 44(3):427-31. PubMed ID: 23026197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.
    Chow K; Bedő J; Ryan A; Agarwal D; Bolton D; Chan Y; Dundee P; Frydenberg M; Furrer MA; Goad J; Gyomber D; Hanegbi U; Harewood L; King D; Lamb AD; Lawrentschuk N; Liodakis P; Moon D; Murphy DG; Peters JS; Ruljancich P; Verrill CL; Webb D; Wong LM; Zargar H; Costello AJ; Papenfuss AT; Hovens CM; Corcoran NM
    Eur J Cancer; 2021 May; 148():440-450. PubMed ID: 33678516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.